In the context of chemotherapy, clinical breast cancer specimens biopsied before and after a course of pre-operative neoadjuvant chemotherapy displayed increased Bcl-2 in residual post-treatment tumor cells [30]. Here, BCL2 is linked to breast carcinoma.